For instance, deficiency in SNORD50A/B snoRNAs can augment the functionalities of K-Ras that ultimately leads to hyperactivated MAPK/ERK signaling and carcinogenesis; and SNORD50A/B deletion occurs at a frequency of >10% in each of 12 common cancers. Here, KRAS is linked to cancer.